Coronavirus: Investors to focus on the upbeat scenario
|Markets are torn between promising vaccine news and grim reality but as US covid cases show tentative signs of flattening, investors could see the glass as half full than half empty, FXStreet’s Analyst Yohay Elam informs.
Key quotes
“Light at the end of the tunnel – Pfizer and BioNTech reported 95% efficacy in their coronavirus candidate, better than 90% initially reporting and topping rivals Moderna. However, production, storage, and distribution challenges mean a long road to the end of that tunnel. After the initial shot in the arm, markets looked back at grim reality.”
“COVID-19 cases continue rising in the northern hemisphere, hitting Europe, the US and even Japan. Governors in various American states have begun introducing restrictions, following governments and regions in the old continent. The potential damage to economic activity – both from lockdowns and from consumer caution – is of concern.”
“A daily average of around 160,000 cases is still worrisome and implies hospitals and mortalities are set to rise. Moreover, this may be a mere consolidation of the uptrend rather than a change of course. Nevertheless, a pause is better than an extension of an uptrend. Also, measures already implemented by various states could still push the curve down.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.